Abnormal miRNA expression is extensively reported in hematologic neoplasms [29-31], one of the genetic lesions most frequently found in CLL cells involves members of the PTEN/PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and hematopoietic and lymphoid system neoplasm.